Alessandro Bartoloni to Immunocompromised Host
This is a "connection" page, showing publications Alessandro Bartoloni has written about Immunocompromised Host.
Connection Strength
0.072
-
Short article: Safety of targeted prophylaxis strategy in patients with resolved hepatitis B virus infection receiving rituximab for immune-mediated diseases. Eur J Gastroenterol Hepatol. 2018 07; 30(7):756-760.
Score: 0.056
-
Threatening drug-drug interaction in a kidney transplant patient with coronavirus disease 2019 (COVID-19). Transpl Infect Dis. 2020 Aug; 22(4):e13286.
Score: 0.016